serine has been researched along with Diabetic Retinopathy in 10 studies
Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this clinical study is to examine the association between D-serine and diabetic retinopathy (DR)." | 7.80 | Increased D-serine in the aqueous and vitreous humour in patients with proliferative diabetic retinopathy. ( Du, J; He, T; Jiang, H; Qu, J; Song, Z; Wu, S, 2014) |
| "The objective of this clinical study is to examine the association between D-serine and diabetic retinopathy (DR)." | 3.80 | Increased D-serine in the aqueous and vitreous humour in patients with proliferative diabetic retinopathy. ( Du, J; He, T; Jiang, H; Qu, J; Song, Z; Wu, S, 2014) |
| "703 patients with type 1 diabetes mellitus from one endocrine department were included in the study." | 1.51 | Protective Effect of the ( Catrina, SB; Chatzidionysiou, K; Ekberg, NR; Eliasson, S; Falhammar, H; Gu, HF; Li, YW; Zheng, X, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malhi, NK | 1 |
| Allen, CL | 1 |
| Stewart, E | 1 |
| Horton, KL | 1 |
| Riu, F | 1 |
| Batson, J | 1 |
| Amoaku, W | 1 |
| Morris, JC | 1 |
| Arkill, KP | 1 |
| Bates, DO | 1 |
| Alka, K | 1 |
| Mohammad, G | 1 |
| Kowluru, RA | 1 |
| Eade, KT | 1 |
| Ansell, BRE | 1 |
| Giles, S | 1 |
| Fallon, R | 1 |
| Harkins-Perry, S | 1 |
| Nagasaki, T | 1 |
| Tzaridis, S | 1 |
| Wallace, M | 1 |
| Mills, EA | 1 |
| Farashi, S | 1 |
| Johnson, A | 1 |
| Sauer, L | 1 |
| Hart, B | 1 |
| Diaz-Rubio, ME | 1 |
| Bahlo, M | 1 |
| Metallo, C | 1 |
| Allikmets, R | 1 |
| Gantner, ML | 1 |
| Bernstein, PS | 1 |
| Friedlander, M | 1 |
| Ekberg, NR | 1 |
| Eliasson, S | 1 |
| Li, YW | 1 |
| Zheng, X | 1 |
| Chatzidionysiou, K | 1 |
| Falhammar, H | 1 |
| Gu, HF | 1 |
| Catrina, SB | 1 |
| Jiang, H | 2 |
| Du, J | 1 |
| He, T | 1 |
| Qu, J | 2 |
| Song, Z | 1 |
| Wu, S | 2 |
| Li, X | 1 |
| Liu, X | 1 |
| Guo, H | 1 |
| Zhao, Z | 1 |
| Li, YS | 1 |
| Chen, G | 1 |
| Zhang, HM | 1 |
| Chen, LL | 1 |
| Wang, L | 1 |
| Liao, YF | 1 |
| Wu, ZH | 1 |
| Ye, F | 1 |
| Xu, S | 1 |
| Yi, LL | 1 |
| Panjala, SR | 1 |
| Jiang, Y | 1 |
| Kern, TS | 1 |
| Thomas, SA | 1 |
| Steinle, JJ | 1 |
| Fang, J | 1 |
| Wu, B | 1 |
| Yin, G | 1 |
| Sun, L | 2 |
| Barger, SW | 1 |
| Al-Kateb, H | 1 |
| Boright, AP | 1 |
| Mirea, L | 1 |
| Xie, X | 1 |
| Sutradhar, R | 1 |
| Mowjoodi, A | 1 |
| Bharaj, B | 1 |
| Liu, M | 1 |
| Bucksa, JM | 1 |
| Arends, VL | 1 |
| Steffes, MW | 1 |
| Cleary, PA | 1 |
| Sun, W | 1 |
| Lachin, JM | 1 |
| Thorner, PS | 1 |
| Ho, M | 1 |
| McKnight, AJ | 1 |
| Maxwell, AP | 1 |
| Savage, DA | 1 |
| Kidd, KK | 1 |
| Kidd, JR | 1 |
| Speed, WC | 1 |
| Orchard, TJ | 1 |
| Miller, RG | 1 |
| Bull, SB | 1 |
| Paterson, AD | 1 |
1 trial available for serine and Diabetic Retinopathy
| Article | Year |
|---|---|
Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications G
Topics: Alanine; Albuminuria; Amino Acid Substitution; Diabetic Nephropathies; Diabetic Retinopathy; Disease | 2008 |
9 other studies available for serine and Diabetic Retinopathy
| Article | Year |
|---|---|
Serine-arginine-rich protein kinase-1 inhibition for the treatment of diabetic retinopathy.
Topics: Animals; Arginine; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Humans; Hyperglycemia; Mac | 2022 |
Regulation of serine palmitoyl-transferase and Rac1-Nox2 signaling in diabetic retinopathy.
Topics: Animals; Ceramides; Cytosine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic R | 2022 |
iPSC-derived retinal pigmented epithelial cells from patients with macular telangiectasia show decreased mitochondrial function.
Topics: Diabetic Retinopathy; Epithelial Cells; Humans; Induced Pluripotent Stem Cells; Mitochondria; Retina | 2023 |
Protective Effect of the
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Di | 2019 |
Increased D-serine in the aqueous and vitreous humour in patients with proliferative diabetic retinopathy.
Topics: Aged; Aqueous Humor; Case-Control Studies; Chromatography, High Pressure Liquid; Diabetes Mellitus, | 2014 |
The significance of the increased expression of phosphorylated MeCP2 in the membranes from patients with proliferative diabetic retinopathy.
Topics: Adult; Aged; Cell Line; Cobalt; Diabetic Retinopathy; Epiretinal Membrane; Eye Proteins; Female; Hum | 2016 |
Association of 1704G/T and G82S polymorphisms in the receptor for advanced glycation end products gene with diabetic retinopathy in Chinese population.
Topics: Adult; Aged; Amino Acid Substitution; Case-Control Studies; China; Diabetes Mellitus, Type 2; Diabet | 2009 |
Increased tumor necrosis factor-α, cleaved caspase 3 levels and insulin receptor substrate-1 phosphorylation in the β₁-adrenergic receptor knockout mouse.
Topics: Animals; Apoptosis; Blotting, Western; Capillaries; Caspase 3; Cell Extracts; Diabetes Complications | 2011 |
Overexpression of serine racemase in retina and overproduction of D-serine in eyes of streptozotocin-induced diabetic retinopathy.
Topics: Animals; Aqueous Humor; Blood Glucose; Body Weight; Cell Death; Diabetes Mellitus, Experimental; Dia | 2011 |